We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




AI-Driven Imaging Platform Analyzes MRI Data for Early Detection of Age-Related Diseases

By MedImaging International staff writers
Posted on 10 May 2023
Image: The AI-powered platform offers a game-changing solution for age-related disease detection and management (Photo courtesy of Freepik)
Image: The AI-powered platform offers a game-changing solution for age-related disease detection and management (Photo courtesy of Freepik)

The increasing prevalence of age-related illnesses and their effects on patients, healthcare systems, and economies present a substantial challenge in the healthcare sector. As the global population ages, there is an urgent need for more efficient, proactive diagnostic tools to detect and manage these conditions at an early stage. An AI-driven imaging platform now aims to transform the early identification of age-related diseases.

Twinn.health (London, UK) has introduced an AI-based imaging platform that utilizes sophisticated AI algorithms to examine MRI data and offer risk assessments for common causes of frailty up to a decade earlier than current techniques. Twinn.health's platform is the first to employ MRI data for risk evaluation in relation to frailty. It detects chronic age-related diseases earlier than conventional molecular signals, making it a powerful tool for early intervention and prevention.

The Twinn.health platform uses heatmaps for visual representations of areas of concern and adipose tissue within MRI scans. It provides AI-generated scores reflecting a patient's risk for highlighted diseases and generates comprehensive case reports summarizing key findings and analysis. The platform has been validated through a retrospective clinical study involving 400 patients and three radiologists, yielding promising outcomes.

"Twinn.health's AI-powered platform offers a game-changing solution for age-related disease detection and management," said Dr. Wareed Alenaini, Founder and CEO of Twinn.health. "Our mission is to unlock the true potential of imaging data to improve health outcomes and prevent multiple diseases with a single MRI scan."

Related Links:
Twinn.health

Ultrasound Table
Women’s Ultrasound EA Table
40/80-Slice CT System
uCT 528
Multi-Use Ultrasound Table
Clinton
X-ray Diagnostic System
FDX Visionary-A

Channels

Ultrasound

view channel
Image: The new implantable device for chronic pain management is small and flexible (Photo courtesy of The Zhou Lab at USC)

Wireless Chronic Pain Management Device to Reduce Need for Painkillers and Surgery

Chronic pain affects millions of people globally, often leading to long-term disability and dependence on opioid medications, which carry significant risks of side effects and addiction.... Read more

Nuclear Medicine

view channel
Image: The diagnostic tool could improve diagnosis and treatment decisions for patients with chronic lung infections (Photo courtesy of SNMMI)

Novel Bacteria-Specific PET Imaging Approach Detects Hard-To-Diagnose Lung Infections

Mycobacteroides abscessus is a rapidly growing mycobacteria that primarily affects immunocompromised patients and those with underlying lung diseases, such as cystic fibrosis or chronic obstructive pulmonary... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.